Abstract
In the last several decades, the major underlying etiology of heart failure (HF) has shifted from hypertension to coronary artery disease (CAD). CAD is the most common cause of heart failure. HF is a highly prevalent syndrome with a poor prognosis, resulting in substantial morbidity and reduced quality of life despite recent advances in treatment. Also, HF is the most common cause of hospital admission in the United States and Europe, and HF hospitalization per se is linked to adverse outcome and high-treatment costs. Despite the progress in the management, the mortality rates remain high, with only modest improvements in survival during the past decades. Coronary artery bypass grafting (CABG) is the most common cardiac surgical procedure and an effective method of relieving angina and improving the prognosis for selected patients with ischemic heart disease. The patients with ischemic heart failure with prior CABG show a pattern similar to that seen in patients without prior CABG. Beyond surgery, optimal secondary prevention, including medications and lifestyle modification, may have significant influence on prolonging vein graft patency and/or reducing clinical events rates in patients undergoing CABG surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mentz RJ, Allen BD, Kwasny MJ, et al. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. Eur J Heart Failure. 2013;15:61–8.
Olsson D, Sartipy U, Braunschweig F, et al. Acute kidney injury following coronary artery bypass surgery and long-term risk of heart failure. Circ Heart Failure. 2013;6:83–90.
Nicolini F, Gherli T. Alternatives to transplantation in the surgical therapy for heart failure. Eur J Cardiothorac Surg. 2009;35:214–28.
Brettell R, Soljak M, Cecil E, et al. Reducing heart failure admission rates in England 2004–2011 are not related to changes in primary care quality: national observation study. Eur J Heart Failure. 2013;15:1335–42.
McMurray JJV, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847.
Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137–46.
Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after PCI with drug-eluting stents or coronary artery bypass surgery. N Eng J Med. 2011;364:1016–26.
Lewis EF, Solomon SD, Jablonski KA, et al. Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. Circ Heart Failure. 2009;2:209–16.
Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction. J Am Coll Cardiol. 2013;62:263–71.
Desai A. Heart failure with preserved ejection fraction: time for a new approach? J Am Coll Cardiol. 2013;62:272–4.
DeMaria AN, Adler ED, Bax JJ, et al. Highlights of the year in JACC 2013. J Am Coll Cardiol. 2014;6(63):570–602.
Khan RS, Kato TS, Chokshi A, et al. Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Failure. 2012;5:340–8.
Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–442.
Montera MW, Almeida DR, Tinoco EM, et al. Sociedade Brasileira de Cardiologia. II Diretriz Brasileira de Insuficiência Cardíaca Aguda. Arq Bras Cardiol. 2009;93(3 supl 3):1–65.
Bocchi EA, Marcondes-Braga FG, Bacal F, et al. Sociedade Brasileira de Cardiologia. Atualização da Diretriz Brasileira de Insuficiência Cardíaca Crônica 2012. Arq Bras Cardiol. 2012;98(1 supl 1):1–33.
Yancy CW, et al. ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American College of Chest Physicians, Heart Rhythm Society and International Society for Heart and Lung Transplantation. Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation. J Am Coll Cardiol. 2013;62(16):e147–239.
Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2012;59:857–81.
Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50:768–77.
Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115:1563–70.
Goldman L, Hashimoto B, Cook EF, et al. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227–34.
Madsen BK, Hansen JF, Stokholm KH, et al. Chronic congestive heart failure: description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J. 1994;15:303–10.
McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med. 2010;362:228–38.
Stewart S, Ekman I, Ekman T, et al. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes. 2010;3:573–80.
Moreyra AE, Deng Y, Wilson AC, et al. Incidence and trends of heart failure admissions after coronary artery bypass grafting surgery. Eur J Heart Failure. 2013;15:46–53.
Lopes RD, Mehta RH, Hafley GE, et al. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012;125:749–56.
Kolh P, Wijns W, Danchin N, et al. Guidelines on myocardial revascularization. The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2010;38(S1):S1–52.
Henkel MD, Redfield MM, Weston SA, et al. Death in heart failure: a community perspective. Circ Heart Failure. 2008;1:91–7.
Cleland JG, Coletta AP, Freemantle N, et al. Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET and EVEREST II. Eur J Heart Failure. 2011;13:227–33.
Westenbrink BD, Damman K, Rienstra M, et al. Heart failure highlights in 2011. Eur J Heart Failure. 2012;14:1090–6.
Cleland JGF, Coletta AP, Buga L, et al. Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR. Eur J Heart Failure. 2010;12:623–9.
Shah RV, Holmes D, Anderson M, et al. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry. Circ Heart Failure. 2012;5:693–702.
The VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the Veteran Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation. 1992;86:121–30.
Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2335–44.
Gheorghiade M, Flaherty JD, Fonarow GC, et al. Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure. Int J Cardiol. 2011;151(1):69–75.
Pagano D, Camici PG, Bonser RS. Revascularisation for chronic heart failure: a valid option? Eur J Heart Failure. 1999;1:269–73.
Berry C, Pieper KS, White HD, et al. Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Eur Heart J. 2009;30:1450–9.
Goldberg RJ, Currie K, White K, et al. Six-months outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events – GRACE). Am J Cardiol. 2004;93:288–93.
Bauernschimitt R, Malberg H, Wessel N, et al. Impairment of cardiovascular autonomic control in patients early after cardiac surgery. Eur J Cardiothorac Surg. 2004;25:320–6.
Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angioghaphy after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol. 2009;53:232–41.
Sabik III JF, Blackstone EH, Houghtaling PL, et al. Is reoperation still a risk factor in coronary artery bypass surgery? Ann Thorac Surg. 2005;80:1719–27.
Fihn SD, Gardin JM, et al. ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary. J Am Coll Cardiol. 2012;60(24):e44–164.
Gurfinkel EP, Perez de la Hoz R, Brito VM, et al. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery. Int J Cardiol. 2007;119:65–72.
Pfautsch P, Frantz E, Ellmer A, et al. Long-term outcome of therapy of recurrent myocardial ischemia after surgical revascularization. Z Kardiol. 1999;88:489–97.
Weintraub WS, Jones EL, Morris DC, et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997;95:868–77.
Wijns W, et al. Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010;31:2501–55.
Sergeant P, Blackstone E, Meyns B, et al. First cardiological or cardiosurgical reintervention for ischemic heart disease after primary coronary artery bypass grafting. Eur J Cardiothorac Surg. 1998;14:480–7.
Fosbol EL, Zhao Y, Shahian DM, Peterson ED, et al. Repeat coronary revascularization after coronary artery bypass surgery in older adults – the Society of Thoracic Surgeons’ National Experience, 1991–2007. Circulation. 2013;127:1656–63.
Penicka M, Bartunek J, Lang O, et al. Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2007;50(14):1315–23.
Cleland JFG, Calvert M, Freemantle N, et al. The heart failure revascularization. Trial HEART. Eur J Heart Failure. 2011;13:227–33.
Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290–5.
Seshadri N, Whitlow PL, Acharya N, et al. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 2002;106:2346–50.
Tabet JY, Meurin P, Beauvais F, et al. Absence of exercise capacity improvement after exercise training program: a strong prognostic factor in patients with chronic heart failure. Circ Heart Failure. 2008;1:220–6.
Vanhees L, Fagard R, Thijs L, et al. Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery. Am J Cardiol. 1995;76:1014–9.
Kunadian V, Zaman A, Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. Eur J Heart Failure. 2011;13:773–84.
Smith Jr SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47:2130–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
da Costa, É.S.M. (2016). Heart Failure After CABG. In: Ţintoiu, I., Underwood, M., Cook, S., Kitabata, H., Abbas, A. (eds) Coronary Graft Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-26515-5_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-26515-5_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26513-1
Online ISBN: 978-3-319-26515-5
eBook Packages: MedicineMedicine (R0)